Please find below a message from Worldwide Clinical Trials’ President and COO, Peter Benton on COVID-19.
In these challenging times, Worldwide Clinical Trials’ core mission – to work with passion and purpose every day to improve patient lives – has never been more important. As the spread of COVID-19 continues as a concern across the world, I want to assure you that Worldwide is taking all measures necessary to protect your corporate goals and objectives while safeguarding the welfare of patients, the investigative research centers that serve them, our partners and the health and well-being of our employees and your research teams.
We recognize that things are changing rapidly now. But our team is rising to the occasion, and I am encouraged by the trust and resilience of our customers and partners as we face this challenge together with flexibility, creativity, contingency planning and constant communication.
As part of our business continuity plans, Worldwide has activated a COVID-19 executive council comprised of leadership from all functional areas across the globe. This team meets daily to discuss and proactively plan for the impact of global, country, state and local updates, including:
- Guidance and updates from the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and the European Centre for Disease Prevention and Control (ECDC), among others
- Regulatory updates relating to the current research environment
- Site-specific updates
- Vendor updates
- Local school and office closings
If you are a current customer, you will have already received requests from our team to engage in dialogue. Depending on your unique trial requirements, our teams will work with you to develop business continuity plans to enable dependable delivery of our commitments. These may include:
- Virtual, Centralized Monitoring
- Flexible Patient Care – In-Home Care
- Virtual Investigator Meetings
- Travel Support and Logistics
It’s important that you know that, as a company who cares deeply about our employees, we’ve been carefully considering everything we can do to help the situation. We have restricted nonessential travel, moved to virtual work where we can, and ensured all employees have easy access to up-to-date guidance. And, leaders across Worldwide, ever mindful of the toll these uncertain times can take, continue to find creative ways to motivate and celebrate the contributions of our team.
Lastly, we are heartened by our compassionate and loyal community of customers and partners. In times like these, we listen, we learn, and we support one another. I thank you for continuing to place your trust and confidence in Worldwide, and I am very proud of our team’s tireless efforts to always be there for each other – and for you.
Together, we will take this one day, and one trial, at a time,
Peter
Peter Benton
President and COO
Worldwide Clinical Trials
